Strategic Financial Concepts LLC Invests $2.45 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Strategic Financial Concepts LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, Holdings Channel reports. The fund acquired 27,168 shares of the exchange traded fund’s stock, valued at approximately $2,447,000.

Several other institutional investors and hedge funds have also made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth $141,284,000. Assetmark Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after purchasing an additional 588,489 shares during the last quarter. Sivik Global Healthcare LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth $29,640,000. Finally, Mirae Asset Securities USA Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $90.34 on Tuesday. The firm has a fifty day moving average price of $92.40 and a 200 day moving average price of $96.38. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a market cap of $6.89 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.